Trastuzumab (Herceptin®) 600mg/5ml solution for Injection
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- not specified
- Value
- £27M
- Sector
- HEALTH
- Published
- 11 Mar 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Geochart for 2 buyers and 1 suppliers
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Roche Products Welwyn Garden City
Description
The supply of Trastuzumab (Herceptin®) 600mg/5ml solution for Injection to NHS Scotland
Total Quantity or Scope
The supply of Trastuzumab (Herceptin®) 600mg/5ml solution for Injection to NHS Scotland.
Award Detail
| 1 | Roche Products (Welwyn Garden City)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Legal Justification
The medicine awarded to this Framework Agreement are, and will continue to be, protected by patent for the duration of the Framework Agreement.
Other Information
The estimated value in Sections II.1.7 and V.2.4 covers the thirty (30) month duration of the Framework Agreement and the eighteen (18) month extension option. (SC Ref:646987)
Reference
- FTS 004908-2021